Skip to main content
Fig. 4 | BMC Pulmonary Medicine

Fig. 4

From: Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer

Fig. 4

Cut-off selection of MPE Hsp90-beta by ROC curve analysis. a, b Selection of cut-off for serum value of Hsp90-beta in distinguishing lung cancer patients from control individuals (sensitivity 84.11%; specificity 86%); receiver operating characteristic curves for Hsp90-beta [area under the curve (auc): 0.796]. c, d Selection of cut-off for serum value of Hsp90-beta in distinguishing lung cancer patients from control individuals (sensitivity 93.46%; specificity 79%); receiver operating characteristic curves for Hsp90-beta [area under the curve (auc): 0.839]. ROC, receiver operating characteristic curve

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us